| Name | Section 160: Pharmacogenomics and Personalized Medicine in CBS/PSP |
| Summary | Pharmacogenomic testing for movement disorder medications, CYP450 genotyping for levodopa/antidepressants/drugs, gene-drug interactions in CBS/PSP treatment, clinical implementation, testing services, decision framework |